SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-345431
Filing Date
2012-08-09
Accepted
2012-08-09 06:47:10
Documents
12
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d354895d10q.htm 10-Q 505304
2 EX-3.1 d354895dex31.htm EX-3.1 416838
3 EX-31.1 d354895dex311.htm EX-31.1 6979
4 EX-31.2 d354895dex312.htm EX-31.2 6995
5 EX-32.1 d354895dex321.htm EX-32.1 3797
6 EX-32.2 d354895dex322.htm EX-32.2 3815
  Complete submission text file 0001193125-12-345431.txt   3335185

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT idra-20120630.xml EX-101.INS 339605
8 XBRL TAXONOMY EXTENSION SCHEMA idra-20120630.xsd EX-101.SCH 36917
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE idra-20120630_cal.xml EX-101.CAL 41021
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE idra-20120630_def.xml EX-101.DEF 56072
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE idra-20120630_lab.xml EX-101.LAB 230147
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idra-20120630_pre.xml EX-101.PRE 156047
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 121018445
SIC: 2836 Biological Products, (No Diagnostic Substances)